Ansell Limited

Ansell Limited

28.80
EUR
0.00
(0.00%)
1.28EPS
15.25P/E
2.72BMarket Cap
Feb 22Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
Revenue per Share
10.52
8.28
7.73
7.18
7.67
7.78
8.55
11.84
15.4
13.1
12.58
13.79
14.99
Basic EPS, GAAP
0.28
0.94
0.78
0.77
2.49
0.58
0.84
1.44
1.25
1.17
0.59
0.7
1.46
Free Cash Flow per Basic Share
1.2
0.88
1.21
1.2
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.34
0.3
0.3
0.32
0.32
0.31
0.33
0.45
0.68
0.5
0.41
0.44
0.55
Book Value per Share
6.94
5.79
5.65
6.33
7.99
7.42
7.47
9.14
12.26
12.7
13.04
13.52
14.28
Tangible Book Value per Share
0.35
0.18
0.22
0.84
2.63
1.68
1.75
2.79
3.92
4.29
5.78
2.12
2.41
Basic Weighted Avg Shares
143
153
151
148
144
135
130
128
127
126
129
145
143
Sales/Revenue/Turnover
1,500
1,268
1,171
1,058
1,103
1,053
1,114
1,521
1,952
1,655
1,619
2,003
2,140
Operating Margin (%)
9.42
12.32
12.63
9.67
10.29
10.98
11.25
13.11
8.78
8.45
3.5
5.45
11.25
Depreciation Expense
33
27
28
35
29
27
26
48
65
68
73
75
80
Net Income, GAAP
39
144
118
114
359
78
110
185
159
148
77
102
209
Effective Tax Rate (%)
32.01
15.5
24.52
21.86
3.23
21.29
20.86
21.94
23.32
20.94
28.7
28.01
25.04
Profit Margin (%)
2.63
11.4
10.12
10.75
32.51
7.45
9.83
12.17
8.13
8.96
4.72
5.07
9.75
Working Capital
522
438
396
538
632
454
382
463
624
497
1,200
589
620
LT Debt
974
566
511
552
409
369
676
371
468
377
780
725
684
Total Equity
1,076
899
846
946
1,148
991
969
1,174
1,557
1,615
1,910
1,983
2,022
Return on Invested Capital (%)
1.88
7.64
7.87
5.51
5.99
4.47
6.44
9.48
7.23
5.29
1.65
2.81
6.43
Return on Capital (%)
3.29
9.06
9.26
8.92
24.5
6.09
7.83
12.01
9.52
7.74
3.71
4.66
8.53
Return on Common Equity (%)
4.52
14.83
13.76
12.87
34.67
7.41
11.28
17.42
11.73
9.43
4.38
5.27
10.55

Capital Structure

USD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

USD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.88%
12.09%
1.99%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
31.07%
13.78%
105.31%
Sales/Revenue/Turnover
7.39%
8.31%
6.83%
Total Cash Common Dividend
8%
10.03%
23.7%

Semi-annual Revenue

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
1,619
2025
- -
- -
2,003
2026
- -
- -
2,140

Semi-annual Earnings Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.59
2025
- -
- -
0.7
2026
- -
- -
1.46

Semi-annual Dividends Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.41
2025
- -
- -
0.44
2026
- -
- -
0.55

Company Description

CEO
Nathalie Ahlström
Full Time Employees
15,409
Sector
Producer manufacturing
Industry
Miscellaneous manufacturing
Address
678 Victoria Street Richmond VIC Australia 3121
IPO Date
Jan 2, 1981
Website
ansell.com
Business
Ansell Limited, a global leader in protection solutions listed on the ASX as ANN.AX, designs, develops, manufactures, distributes and sells hand and body protective equipment primarily through its Healthcare and Industrial segments; Healthcare offers surgical gloves including GAMMEX non-latex and GAMMEX gamma-sterilized disposable surgeons gloves, single-use and examination gloves, cleanroom and sterile gloves and garments under brands such as BioClean, MICROFLEX and consumables for hospitals, surgical centers, dental practices, veterinary clinics, laboratories, life sciences and pharmaceutical companies; Industrial provides hand protection gloves such as HyFlex Precision Comfort Series with AEROFIT Technology, chemical protective clothing and solutions for automotive, chemical processing, metal fabrication, machinery, food processing, construction, mining, oil and gas applications and first responders. Founded in 1893 through Eric Norman Ansell's acquisition of condom machinery from Dunlop with roots tracing to 1929 Dunlop operations and formerly known as Pacific Dunlop Limited until its 2002 name change, the company maintains headquarters in Richmond, Victoria, Australia, with operational headquarters in Red Bank, New Jersey, USA, and employs over 15,000 people across more than 100 countries spanning Asia Pacific, Europe, Middle East, Africa, North America and Latin America/Caribbean. Ansell targets industrial workers, healthcare professionals, laboratories and cleanroom environments with a focus on innovation, sustainability via Ansell Earth recycled PPE and initiatives like the RightCycle program for non-hazardous waste disposal. In recent developments, Ansell completes the 2024 acquisition of Kimberly-Clark's Personal Protective Equipment business adding Kimtech, KleenGuard brands and RightCycle capabilities with sales expansion into North America and Europe in 2025, launches the HyFlex Precision Comfort Series industrial gloves, acquires Sandel Medical Industries and RINGERS to bolster medical and industrial portfolios, acquires BioClean for cleanroom expansion, divests its sexual wellness business to streamline as a focused safety solutions provider, expands supplier management in Malaysia, doubles medical sales force in India post-record $2 billion sales during COVID-19 and transitions to a customer-centric growth structure on its 130th anniversary while earning Frost & Sullivan's 2025 Global Sustainable Hospital Supplies Company of the Year award.

Company News

  • Ansell Limited (OTCMKTS:ANSLY) Stock Short Interest Drops 97.8%

  • Ansell Limited (ANSLY) Q4 2026 Earnings Call Transcript

  • Ansell Announces Greenovation(TM) Awards for Sustainability Leadership and Waste Reduction

  • Marissa Ansell on Active ETFs, Goldman Sachs Funds & More

  • Ansell H1 Earnings Call Highlights

  • Ansell Limited (ANSLY) Q2 2026 Earnings Call Transcript

  • Ansell (OTCMKTS:ANSLY) Shares Down 5.5% – What’s Next?

  • Ansell Limited (OTCMKTS:ANSLY) Sees Significant Decline in Short Interest

  • Ansell Limited (ANSLY) Shareholder/Analyst Call Transcript

  • Ansell Limited (ANSLF) Q4 2025 Earnings Call Transcript

  • Ansell Limited (ANSLF) Q2 2025 Earnings Call Transcript

  • Australia Personal Protective Equipment Market Outlook Report 2024-2033 Featuring Medline Industries, Molnlycke Health Care, Ansell, and 3M

  • Ansell Limited (ANSLF) Q2 2024 Earnings Call Transcript

  • Ansell Limited (ANSLF) Q2 2023 Earnings Call Transcript

  • Ansell Limited (ANSLF) CEO Neil Salmon on Q4 2022 Results - Earnings Call Transcript

  • Ansell Limited (ANSLF) CEO Neil Salmon on Q2 2022 Results - Earnings Call Transcript

  • PPE Manufacturer Ansell Still Trading at a Nice Valuation